These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1372760

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
    Fottner C, Sattarova S, Hoffmann K, Spöttl G, Weber MM.
    Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
    [Abstract] [Full Text] [Related]

  • 6. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ, Geller NL, Cirrincione C, Nisselbaum J, Vugrin D, Whitmore WF, Golbey RB.
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA, Franceschi T, Lenotti M, Pancheri F, Zaninelli M, Corgnati A, Cetto GL.
    J Nucl Med Allied Sci; 1990 Jul; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract] [Full Text] [Related]

  • 9. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
    Sheinfeld J.
    Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
    Lancet; 1978 Nov 11; 2(8098):1042. PubMed ID: 82048
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Testicular cancer: role of biological tumor markers.
    Pearson JC, Spaulding JT, Friedman MA.
    Cancer Treat Rev; 1979 Dec 11; 6(4):217-21. PubMed ID: 93978
    [No Abstract] [Full Text] [Related]

  • 16. Testicular cancer: risk stratification in adolescents with nonseminoma.
    Looijenga LH.
    Nat Rev Urol; 2014 Jul 11; 11(7):367-8. PubMed ID: 24960597
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
    Schwartz MK.
    Tumour Biol; 1987 Jul 11; 8(2-3):106-8. PubMed ID: 2452467
    [No Abstract] [Full Text] [Related]

  • 18. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
    Wood DP, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ.
    Cancer; 1992 Nov 01; 70(9):2354-7. PubMed ID: 1382832
    [Abstract] [Full Text] [Related]

  • 19. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK, Stephenson AJ, Gilligan T, Klein EA.
    Urol Clin North Am; 2007 May 01; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [Abstract] [Full Text] [Related]

  • 20. Clinical analysis of management of pediatric testicular germ cell tumors.
    Ye YL, Sun XZ, Zheng FF, Bian J, Huang YP, Zhang XQ, Li ZX, Nie Y, Qin ZK, Dai YP.
    Urology; 2012 Apr 01; 79(4):892-7. PubMed ID: 22305424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.